ESO-话题@MedSci

#ESO#

55篇内容 | 2101人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1493316, encodeId=7ec8149331685, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=FRBM：急性缺血性中风合并糖尿病患者炎症反应紊乱，Resolvin D2治疗可挽救炎症反应, objectType=article, longId=733000, objectId=05cde33000b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05cde33000b8, replyNumber=0, likeNumber=98, createdTime=2022-07-23, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05cde33000b8, moduleTitle=FRBM：急性缺血性中风合并糖尿病患者炎症反应紊乱，Resolvin D2治疗可挽救炎症反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05cde33000b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493315, encodeId=363714933159f, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=J Allergy Clin Immunol：研究揭示spesolimab治疗脓疱型银屑病的分子机制, objectType=article, longId=725898, objectId=b8bde25898e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8bde25898e9, replyNumber=0, likeNumber=96, createdTime=2022-05-02, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8bde25898e9, moduleTitle=J Allergy Clin Immunol：研究揭示spesolimab治疗脓疱型银屑病的分子机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8bde25898e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493314, encodeId=4e95149331479, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点, objectType=article, longId=300734, objectId=5e00300e34a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e00300e34a5, replyNumber=0, likeNumber=137, createdTime=2022-03-16, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e00300e34a5, moduleTitle=经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e00300e34a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493313, encodeId=1c3e149331350, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=JACI:Spesolimab治疗广泛性脓疱性银屑病的分子途径和作用。, objectType=article, longId=292750, objectId=3997292e5052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3997292e5052, replyNumber=0, likeNumber=87, createdTime=2021-12-26, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3997292e5052, moduleTitle=JACI:Spesolimab治疗广泛性脓疱性银屑病的分子途径和作用。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3997292e5052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493312, encodeId=f50d149331291, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=NEJM重磅：新型 IL-36 抗体疗法 spesolimab 可有效快速治疗泛发性脓疱型银屑病 (GPP) 急性发作, objectType=article, longId=292732, objectId=8da4292e32cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8da4292e32cb, replyNumber=0, likeNumber=96, createdTime=2021-12-26, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8da4292e32cb, moduleTitle=NEJM重磅：新型 IL-36 抗体疗法 spesolimab 可有效快速治疗泛发性脓疱型银屑病 (GPP) 急性发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8da4292e32cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493311, encodeId=8f2e1493311df, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Hypertension：Resolvin E1通过抑制Wnt7a/β-Catenin信号减弱肺动脉高压, objectType=article, longId=219433, objectId=25f221943396, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25f221943396, replyNumber=0, likeNumber=85, createdTime=2021-10-30, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25f221943396, moduleTitle=Hypertension：Resolvin E1通过抑制Wnt7a/β-Catenin信号减弱肺动脉高压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25f221943396)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493310, encodeId=9d951493310d3, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=J Urol：Cxbladder Resolve（CxbR）在尿路上皮癌风险患者中的诊断性能如何？, objectType=article, longId=216547, objectId=3cdd21654ee5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cdd21654ee5, replyNumber=0, likeNumber=85, createdTime=2021-09-02, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cdd21654ee5, moduleTitle=J Urol：Cxbladder Resolve（CxbR）在尿路上皮癌风险患者中的诊断性能如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cdd21654ee5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493309, encodeId=00061493309b4, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=LANCET ONCOL：围手术期或术后辅助奥沙利铂联合S-1 vs术后辅助奥沙利铂联合卡培他滨在接受D2胃切除术的局部进展期胃或胃食管结合部腺癌患者的疗效和安全性(RESOLVE): 一项开放标签、优效性和非劣效的3期随机对照研究, objectType=article, longId=214070, objectId=468d2140e0fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468d2140e0fd, replyNumber=0, likeNumber=55, createdTime=2021-07-13, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468d2140e0fd, moduleTitle=LANCET ONCOL：围手术期或术后辅助奥沙利铂联合S-1 vs术后辅助奥沙利铂联合卡培他滨在接受D2胃切除术的局部进展期胃或胃食管结合部腺癌患者的疗效和安全性(RESOLVE): 一项开放标签、优效性和非劣效的3期随机对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468d2140e0fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493308, encodeId=8feb1493308ac, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=勃林格殷格翰同类首创在研免疫新药Spesolimab获得CDE突破性治疗药物认定, objectType=article, longId=213247, objectId=3f8321324e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f8321324e7a, replyNumber=0, likeNumber=82, createdTime=2021-06-27, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f8321324e7a, moduleTitle=勃林格殷格翰同类首创在研免疫新药Spesolimab获得CDE突破性治疗药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f8321324e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493307, encodeId=59b1149330e34, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=J Cardiovasc Magn Reson：利用高分辨率心血管磁共振识别颅内动脉夹层的高危临床和影像学特征, objectType=article, longId=212952, objectId=1ec6212952c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ec6212952c9, replyNumber=0, likeNumber=82, createdTime=2021-06-21, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ec6212952c9, moduleTitle=J Cardiovasc Magn Reson：利用高分辨率心血管磁共振识别颅内动脉夹层的高危临床和影像学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ec6212952c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493306, encodeId=d3241493306f6, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Journal of Cardiovascular Magnetic Resonance：用定量心血管磁共振心肌灌注图表征左内乳冠状动脉搭桥术患者的心肌缺血, objectType=article, longId=212951, objectId=8df9212951c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df9212951c4, replyNumber=0, likeNumber=133, createdTime=2021-06-21, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df9212951c4, moduleTitle=Journal of Cardiovascular Magnetic Resonance：用定量心血管磁共振心肌灌注图表征左内乳冠状动脉搭桥术患者的心肌缺血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df9212951c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493305, encodeId=5858149330573, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Journal of Cardiovascular Magnetic Resonance:冠脉狭窄是否严重，查一下CMRA, objectType=article, longId=211508, objectId=238c21150815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=238c21150815, replyNumber=0, likeNumber=0, createdTime=2021-05-20, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=238c21150815, moduleTitle=Journal of Cardiovascular Magnetic Resonance:冠脉狭窄是否严重，查一下CMRA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=238c21150815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493304, encodeId=04791493304fa, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=A型血友病，Efanesoctocog alfa被FDA授予“快速通道资格”, objectType=article, longId=207423, objectId=044820e4234d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044820e4234d, replyNumber=0, likeNumber=71, createdTime=2021-02-23, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044820e4234d, moduleTitle=A型血友病，Efanesoctocog alfa被FDA授予“快速通道资格”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=044820e4234d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493303, encodeId=3e3714933031e, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Catheter Cardiovasc Interv：R-ZES在ST-Elevation心肌梗死患者中的安全性和有效性——Resolute-STEMI试验, objectType=article, longId=203341, objectId=5b9320334148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9320334148, replyNumber=0, likeNumber=68, createdTime=2020-11-15, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9320334148, moduleTitle=Catheter Cardiovasc Interv：R-ZES在ST-Elevation心肌梗死患者中的安全性和有效性——Resolute-STEMI试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9320334148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493302, encodeId=d907149330224, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Mol Ther：慢病毒转导的CART-meso在晚期实体癌中的I期研究, objectType=article, longId=201443, objectId=995e20144349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=995e20144349, replyNumber=0, likeNumber=103, createdTime=2020-10-02, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=995e20144349, moduleTitle=Mol Ther：慢病毒转导的CART-meso在晚期实体癌中的I期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=995e20144349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493301, encodeId=99d81493301b0, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Circulation：ω-3多不饱和脂肪酸通过resolvin E1-ChemR23轴减轻主动脉瓣狭窄, objectType=article, longId=199978, objectId=b20b1999e88a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b20b1999e88a, replyNumber=0, likeNumber=52, createdTime=2020-08-29, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b20b1999e88a, moduleTitle=Circulation：ω-3多不饱和脂肪酸通过resolvin E1-ChemR23轴减轻主动脉瓣狭窄, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b20b1999e88a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493300, encodeId=9162149330099, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Clin Exp Allergy：可溶性Budesonide鼻喷雾在过敏性鼻炎中的快速效应 , objectType=article, longId=197508, objectId=d10c19e508e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d10c19e508e7, replyNumber=0, likeNumber=0, createdTime=2020-07-16, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d10c19e508e7, moduleTitle=Clin Exp Allergy：可溶性Budesonide鼻喷雾在过敏性鼻炎中的快速效应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d10c19e508e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493299, encodeId=faa614932998e, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=2019 ESO指南：急性脑出血口服抗凝剂逆转, objectType=article, longId=186228, objectId=73931862283f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73931862283f, replyNumber=0, likeNumber=54, createdTime=2020-01-15, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73931862283f, moduleTitle=2019 ESO指南：急性脑出血口服抗凝剂逆转, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73931862283f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493298, encodeId=bef41493298aa, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=爱科百发抗呼吸道合胞病毒新药Ziresovir对住院婴幼儿患者的国际II期临床概念验证试验取得突破性结果, objectType=article, longId=182517, objectId=1d7618251e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d7618251e0b, replyNumber=0, likeNumber=83, createdTime=2019-11-08, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d7618251e0b, moduleTitle=爱科百发抗呼吸道合胞病毒新药Ziresovir对住院婴幼儿患者的国际II期临床概念验证试验取得突破性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d7618251e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493297, encodeId=c7fe149329e29, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=NEJM： Volanesorsen可降低家族性乳糜血症综合征患者甘油三酯, objectType=article, longId=177366, objectId=eb951e7366d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb951e7366d3, replyNumber=0, likeNumber=78, createdTime=2019-08-11, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb951e7366d3, moduleTitle=NEJM： Volanesorsen可降低家族性乳糜血症综合征患者甘油三酯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb951e7366d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ESO

2020-05-29

hongbochen (审核中...)

前往app查看评论内容

#ESO#

FRBM：急性缺血性中风合并糖尿病患者炎症反应紊乱，Resolvin D2治疗可挽救炎症反应

2022-07-23

hongbochen (审核中...)

前往app查看评论内容

#ESO#

J Allergy Clin Immunol：研究揭示spesolimab治疗脓疱型银屑病的分子机制

2022-05-02

hongbochen (审核中...)

前往app查看评论内容

#ESO#

经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点

2022-03-16

hongbochen (审核中...)

前往app查看评论内容

#ESO#

JACI:Spesolimab治疗广泛性脓疱性银屑病的分子途径和作用。

2021-12-26

hongbochen (审核中...)

前往app查看评论内容

#ESO#

NEJM重磅：新型 IL-36 抗体疗法 spesolimab 可有效快速治疗泛发性脓疱型银屑病 (GPP) 急性发作

2021-12-26

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Hypertension：Resolvin E1通过抑制Wnt7a/β-Catenin信号减弱肺动脉高压

2021-10-30

hongbochen (审核中...)

前往app查看评论内容

#ESO#

J Urol：Cxbladder Resolve（CxbR）在尿路上皮癌风险患者中的诊断性能如何？

2021-09-02

hongbochen (审核中...)

前往app查看评论内容

#ESO#

LANCET ONCOL：围手术期或术后辅助奥沙利铂联合S-1 vs术后辅助奥沙利铂联合卡培他滨在接受D2胃切除术的局部进展期胃或胃食管结合部腺癌患者的疗效和安全性(RESOLVE): 一项开放标签、优效性和非劣效的3期随机对照研究

2021-07-13

hongbochen (审核中...)

前往app查看评论内容

#ESO#

勃林格殷格翰同类首创在研免疫新药Spesolimab获得CDE突破性治疗药物认定

2021-06-27

hongbochen (审核中...)

前往app查看评论内容

#ESO#

J Cardiovasc Magn Reson：利用高分辨率心血管磁共振识别颅内动脉夹层的高危临床和影像学特征

2021-06-21

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Journal of Cardiovascular Magnetic Resonance：用定量心血管磁共振心肌灌注图表征左内乳冠状动脉搭桥术患者的心肌缺血

2021-06-21

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Journal of Cardiovascular Magnetic Resonance:冠脉狭窄是否严重，查一下CMRA

2021-05-20

hongbochen (审核中...)

前往app查看评论内容

#ESO#

A型血友病，Efanesoctocog alfa被FDA授予“快速通道资格”

2021-02-23

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Catheter Cardiovasc Interv：R-ZES在ST-Elevation心肌梗死患者中的安全性和有效性——Resolute-STEMI试验

2020-11-15

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Mol Ther：慢病毒转导的CART-meso在晚期实体癌中的I期研究

2020-10-02

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Circulation：ω-3多不饱和脂肪酸通过resolvin E1-ChemR23轴减轻主动脉瓣狭窄

2020-08-29

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Clin Exp Allergy：可溶性Budesonide鼻喷雾在过敏性鼻炎中的快速效应

2020-07-16

hongbochen (审核中...)

前往app查看评论内容

#ESO#

2019 ESO指南：急性脑出血口服抗凝剂逆转

2020-01-15

hongbochen (审核中...)

前往app查看评论内容

#ESO#

爱科百发抗呼吸道合胞病毒新药Ziresovir对住院婴幼儿患者的国际II期临床概念验证试验取得突破性结果

2019-11-08

hongbochen (审核中...)

前往app查看评论内容

#ESO#

NEJM： Volanesorsen可降低家族性乳糜血症综合征患者甘油三酯

2019-08-11

科室
- - 订阅+
  - 更多科室
工具
服务